Loading provider…
Loading provider…
Neurology Physician in Sacramento, CA
NPI: 1396088258Primary Practice Location
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL CENTER
4301 X St, Sacramento, CA
Primary Employer
Regents of the Univ of CA
health.ucdavis.edu
HQ Phone
Get M.D. Mustafa's Phone Numberphone_androidMobile
Get M.D. Mustafa's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2014 - 2026

American Board of Psychiatry and Neurology
Neurology
University of Southern California/LAC+USC Medical Center
Fellowship • Neuroimmunology & Multiple Sclerosis
2017 - 2019
University of California Davis Health
Residency • Neurology
2013 - 2017
UTMB Health
utmb.edu
Medical School
Until 2013
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 109 | 164 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 27 | 27 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 23 | 23 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 16 | 16 |
| 5 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 13 | 17 |
Rituximab during pregnancy in neuromyelitis optica: A case report.
Authors: Lilyana Amezcua, Michael Levy
Publication Date: 2018-09-16
Authors: Akbari, Elham, Hossaini, Dawood, Amiry, Ghulam Yahya, Ansari, Mustafa, Haidary, Murtaza, Beheshti, Farimah, Ahmadi-Soleimani, S Mohammad
Journal: Behav Brain Res
Publication Date: 2022-10-13
Lead Sponsor: University of Utah
Intervention / Treatment: DRUG: Placebo, DRUG: Inebilizumab